US Edition
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
- The Schall Law Firm is urging investors who purchased Soleno Therapeutics, Inc. securities between May 1, 2025 and February 27, 2026 to contact the firm by May 19, 2026 regarding a potential securities class action lawsuit.
- Legal filings claim that Soleno executives misrepresented and concealed evidence of safety concerns regarding DCCR, a drug for Prader-Willi syndrome, specifically downplaying risks of excess fluid retention in clinical trial participants.
- Consequently, the lawsuit alleges Soleno failed to disclose that DCCR had materially lower commercial viability, including undisclosed risks related to patient discontinuation rates, prescriber reluctance, and potential regulatory or legal fallout.
- Investors wishing to serve as lead plaintiff must move the Court by May 5, 2026 to act as a representative party directing the litigation, according to legal filings.
- Until a class is formally certified by the Court, shareholders may participate through a contingency fee arrangement without out-of-pocket costs or remain absent class members and do nothing at this point.
27 Articles
27 Articles
PR Newswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between...
Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied ...
SAN FRANCISCO, March 31, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired Hercules securities between May 1, 2025 and February 27, 2026.
HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall L
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hercules Capital, Inc. ("Hercules" or "the Company") (NYSE:HTGC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between Ma…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
